| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10965697 | Vaccine | 2015 | 7 Pages |
Abstract
In general, vaccination against meningococci gave rise to antibody responses in the C2D patients that equal healthy controls. The response rate was lower to serogroup A and among C2D patients with history of invasive infections. The presence of G2M*n/G2M*n genotype was associated with higher SBA titres after immunization.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Nicholas Brodszki, Lillemor Skattum, Xilian Bai, Helen Findlow, Ray Borrow, Göran Jönsson,